Uber Q4 Earnings: Potential Risks And Robotaxis Stepping Stones — Neutral
UBER Seeking Alpha — January 30, 2026Uber (UBER) is scheduled to report its full fiscal year results next week and repetition of Q3 release is not something that investors want to see. The report will provide a much needed clearance on whether profitability hiccups are here to stay of if they were just a one-off event. A positive update on Nvidia's partnership could be used as a counterweight in an adverse case scenario for margins.
SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval — Positive
SENS Zacks Investment Research — January 30, 2026Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.
Will Tapestry (TPR) Beat Estimates Again in Its Next Earnings Report? — Positive
TPR Zacks Investment Research — January 30, 2026Tapestry (TPR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Primerica (PRI) Beat Estimates Again in Its Next Earnings Report? — Positive
PRI Zacks Investment Research — January 30, 2026Primerica (PRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nasdaq, Inc. continues to outperform, exceeding analyst expectations in both revenue and EPS for Q4 and FY25. NDAQ's operating margins are expanding in Market Services and Capital Access Platform, while overall net revenue grew 12% for FY25. Balance sheet risk has diminished as leverage fell to 2.9x, enabling future growth investments or M&A activity.
Deadline Alert: Bath & Body Works, Inc. (BBWI) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit — Neutral
BBWI GlobeNewsWire — January 30, 2026LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI ) securities between June 4, 2024 and November 19, 2025, inclusive (the “Class Period”). Bath & Body Works investors have until March 16, 2026 to file a lead plaintiff motion.
Deadline Alert: Blue Owl Capital Inc. (OWL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit — Neutral
OWL GlobeNewsWire — January 30, 2026LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR OWL INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
4 Business Services Firms Poised to Beat Estimates This Earnings Season — Positive
COHR EXPO IT TRU Zacks Investment Research — January 30, 2026IT, COHR, EXPO and TRU are set to shine this earnings season, each showing strong growth estimates and solid momentum across the business services sector.
Carter's Wholesale Weakness: Temporary Reset or Structural Shift? — Negative
CRI Zacks Investment Research — January 30, 2026CRI faces U.S. Wholesale pressure from weaker Simple Joys demand on Amazon, prompting a strategic shift toward core brands.
Uber Eats Ordered to Pay $3.5 Million Over NYC Delivery Worker Pay — Negative
UBER WSJ — January 30, 2026The food-delivery business agreed to pay $3.15 million in restitution to 48,000 workers across the city, and $350,000 in civil penalties and fees.
Deadline Alert: Ardent Health, Inc. (ARDT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit — Neutral
ARDT GlobeNewsWire — January 30, 2026LOS ANGELES, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”).
New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug — Negative
LENZ Benzinga — January 30, 2026On Wednesday, the U.S. Food and Drug Administration (FDA) approved Tenpoint Therapeutics Ltd.'s Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop for presbyopia in adults.
Lululemon price target slashed on outgoing CEO's final day — Negative
LULU Proactive Investors — January 30, 2026Jefferies analysts lowered their price target on Lululemon Athletica Inc (NASDAQ:LULU) stock to $185 from $200, coinciding with the outgoing CEO Calvin McDonald's final day at the company. Shares of Lululemon traded at about $174 on Friday, down almost 60% in the last 12 months.
Can Operational Execution Support DaVita's Q4 Performance? — Positive
DVA Zacks Investment Research — January 30, 2026DVA's fourth-quarter 2025 performance is likely to have gained from technology upgrades, cost control and seasonal boosts despite ongoing volume headwinds.
CMCSA Q4 Earnings Beat On Theme Parks and Peacock Strength — Positive
CMCSA Zacks Investment Research — January 30, 2026Comcast tops Q4 EPS and revenues as Theme Parks and Peacock surge, offset by broadband losses, weaker Studios results and margin pressure.
Schneider Q4 Earnings Miss Estimates, Down Year Over Year — Negative
SNDR Zacks Investment Research — January 30, 2026SNDR reports Q4 earnings miss as softer demand and higher costs weigh on results. It expects its 2026 EPS to be in the range of 70 cents-$1.00.
All You Need to Know About 1st Source (SRCE) Rating Upgrade to Buy — Positive
SRCE Zacks Investment Research — January 30, 20261st Source (SRCE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
WisdomTree, Inc. (WT) Reports Q4 Earnings: What Key Metrics Have to Say — Positive
WT Zacks Investment Research — January 30, 2026The headline numbers for WisdomTree, Inc. (WT) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Innovex International (INVX) is a Great Momentum Stock: Should You Buy? — Positive
INVX Zacks Investment Research — January 30, 2026Does Innovex International (INVX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Oceaneering International (OII) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive
OII Zacks Investment Research — January 30, 2026Oceaneering International (OII) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.